Tower Research Capital (TRC)’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,342
Closed -$66K 6850
2022
Q3
$66K Buy
4,342
+233
+6% +$3.54K ﹤0.01% 2917
2022
Q2
$31K Buy
4,109
+3,609
+722% +$27.2K ﹤0.01% 3359
2022
Q1
$5K Sell
500
-11,830
-96% -$118K ﹤0.01% 5160
2021
Q4
$87K Buy
12,330
+9,230
+298% +$65.1K ﹤0.01% 2329
2021
Q3
$35K Sell
3,100
-1,515
-33% -$17.1K ﹤0.01% 3256
2021
Q2
$74K Sell
4,615
-1,280
-22% -$20.5K ﹤0.01% 2683
2021
Q1
$105K Buy
5,895
+4,016
+214% +$71.5K ﹤0.01% 2552
2020
Q4
$26K Sell
1,879
-2,089
-53% -$28.9K ﹤0.01% 3706
2020
Q3
$47K Sell
3,968
-774
-16% -$9.17K ﹤0.01% 3565
2020
Q2
$70K Buy
+4,742
New +$70K ﹤0.01% 2785
2020
Q1
Sell
-2,693
Closed -$65K 4215
2019
Q4
$65K Buy
2,693
+1,071
+66% +$25.9K 0.01% 1178
2019
Q3
$31K Buy
1,622
+164
+11% +$3.13K ﹤0.01% 2175
2019
Q2
$43K Buy
1,458
+1,398
+2,330% +$41.2K ﹤0.01% 1687
2019
Q1
$3K Buy
+60
New +$3K ﹤0.01% 3343
2018
Q4
Sell
-339
Closed -$21K 4540
2018
Q3
$21K Buy
+339
New +$21K ﹤0.01% 2321
2018
Q2
Sell
-503
Closed -$27K 4225
2018
Q1
$27K Buy
503
+433
+619% +$23.2K ﹤0.01% 2025
2017
Q4
$4K Sell
70
-4,581
-98% -$262K ﹤0.01% 3028
2017
Q3
$226K Buy
4,651
+4,414
+1,862% +$214K 0.02% 684
2017
Q2
$12K Buy
+237
New +$12K ﹤0.01% 1534
2016
Q2
Sell
-951
Closed -$12K 5178
2016
Q1
$12K Buy
+951
New +$12K ﹤0.01% 1798
2015
Q4
Sell
-3,461
Closed -$61K 5257
2015
Q3
$61K Buy
3,461
+2,471
+250% +$43.6K 0.01% 885
2015
Q2
$17K Buy
990
+896
+953% +$15.4K ﹤0.01% 2261
2015
Q1
$3K Sell
94
-1,079
-92% -$34.4K ﹤0.01% 3625
2014
Q4
$34K Buy
+1,173
New +$34K ﹤0.01% 1261
2014
Q3
Sell
-2,080
Closed -$52K 5045
2014
Q2
$52K Buy
+2,080
New +$52K 0.01% 1271
2014
Q1
Sell
-1,409
Closed -$25K 5132
2013
Q4
$25K Buy
+1,409
New +$25K ﹤0.01% 2086